CellSource Co., Ltd. (4880.T)

1,344.00 +9.00 (+0.67%) At close: 03:15PM JST

CellSource Co., Ltd.

SHIBUYA CAST.
11th Floor 23-21 Shibuya 1-chome Shibuya-ku
Tokyo 150-0002
Japan
81 3 6455 5308
https://www.cellsource.co.jp

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 151

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Masayuki Yamakawa M.D.	Executive Chairman & MD	N/A	N/A	1964
Mr. Takashi Sawada	Representative Director, President & CEO	N/A	N/A	1957
Mr. Katsuji Onishi	Executive Officer, GM of Mgt. HQ., Head of Mgt. HQ. & GM of Administration	N/A	N/A	1971
Mr. Masato Tsumamoto	CXO, Chief Transformation Officer & Representative Director	N/A	N/A	1982
Mr. Hirohiko Hanaki	Executive Officer & Head of Medical Affairs Headquarters	N/A	N/A	1969
Kaoru Hosoda	Executive Officer & Head of Corporate Planning Headquarters	N/A	N/A	N/A
Mr. Futa Asada	Executive Officer, Head of CPC Headquarters & Director	N/A	N/A	1988

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.

Description

CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients' adipose tissues, and to prepare platelet-rich plasma from patients' blood; and offers support services for medical facilities providing regenerative medicine therapy, as well as manufacturing processed cells. It is also involved in the development and sale of Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

Corporate governance

CellSource Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.